Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39 EUR | +1.04% | +8.33% | 0.00% |
13/06 | Xilio Therapeutics, Inc. Announces Board Appointments | CI |
06/06 | UL Solutions and ScienceMedia Partner to Revolutionize Training and E-Learning Solutions for Life Sciences | CI |
Sales 2024 * | 280.51Cr 262.1Cr 23TCr | Sales 2025 * | 295.18Cr 275.8Cr 25TCr | Capitalization | 828.02Cr 773.67Cr 69TCr |
---|---|---|---|---|---|
Net income 2024 * | 28Cr 26Cr 2.36TCr | Net income 2025 * | 29Cr 27Cr 2.45TCr | EV / Sales 2024 * | 3.15 x |
Net Debt 2024 * | 54Cr 51Cr 4.53TCr | Net Debt 2025 * | 39Cr 37Cr 3.27TCr | EV / Sales 2025 * | 2.94 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
28.3
x | Employees | - |
Yield 2024 * |
1.21% | Yield 2025 * |
1.28% | Free-Float | 19.4% |
1 week | +8.33% | ||
Current month | +9.55% | ||
1 month | +15.83% |
Date | Price | Change |
---|---|---|
14/24/14 | 39 | +1.04% |
13/24/13 | 38.6 | +2.12% |
12/24/12 | 37.8 | +3.85% |
11/24/11 | 36.4 | -0.55% |
10/24/10 | 36.6 | +1.67% |
Real-time BOERSE MUENCHEN, June 15, 2024 at 01:14 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.20% | 258.31Cr | |
-17.27% | 252.35Cr | |
-24.01% | 191.9Cr | |
-9.21% | 103.86Cr | |
-14.19% | 102.11Cr | |
+1.42% | 84Cr | |
-24.64% | 70Cr | |
-7.47% | 70Cr | |
+27.41% | 70Cr |
- Stock Market
- Equities
- ULS Stock
- 72R Stock